The companies have committed to a multi-year research and development effort which will focus on AI empowerment and AI exploration. More: Novartis, Microsoft collab to ‘transform medicine’ with AI Source: News
read moreThis year’s awards ceremony will be taking place at the Chelsea Harbour Hotel on the 14th November. More: Tickets available for the 2019 Sales Awards gala dinner and ceremony Source: News
read moreThe drug improved progression-free survival to 8.2 months from 6.3 months. More: Tecentriq combo proves effective in bladder cancer Source: News
read moreGlaxoSmithKline presented the results at the ESMO Congress. More: Zejula successful in advanced ovarian cancer Source: News
read moreMarketing applications for the treatments are currently being reviewed by the EMA. More: Novartis announces positive asthma results Source: News
read moreDriven by the idiopathic pulmonary fibrosis market, Boehringer Ingelheim’s Ofev finally hit blockbuster sales in 2018. An FDA nod in a rare lung disease, Ofev is targeting even more small indications to add to its portfolio. More: Boehringer Ingelheim's
read more© 1994 - 2026 B.M. Pharmaceuticals